Inhibiting the transcription factor HSF1 as an anticancer strategy
- PMID: 19335068
- DOI: 10.1517/14728220902832697
Inhibiting the transcription factor HSF1 as an anticancer strategy
Abstract
Background: In mammals, the cytoprotective heat-shock response is regulated primarily by heat shock factor 1 (HSF1). Unfortunately, the effects of HSF1 also support the ability of cancer cells to accommodate imbalances in signaling and alterations in DNA, protein and energy metabolism associated with oncogenesis. The malignant lifestyle confers dependence on this 'non-oncogene', suggesting a therapeutic role for HSF1 inhibitors.
Objective/methods: We begin with an overview of how HSF1 affects cancer biology and how its activity is regulated. We then summarize progress in discovery and development of HSF1 inhibitors, their current limitations and potential as anticancer agents with a fundamentally different scope of action from other clinically validated modulators of protein homeostasis.
Results/conclusions: It is likely that within the next 5 years usable inhibitors of HSF1 will be identified and in early pre-clinical evaluation.
Similar articles
-
The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma.Br J Haematol. 2013 Feb;160(4):465-76. doi: 10.1111/bjh.12164. Epub 2012 Dec 18. Br J Haematol. 2013. PMID: 23252346
-
Novel isoforms of heat shock transcription factor 1, HSF1γα and HSF1γβ, regulate chaperone protein gene transcription.J Biol Chem. 2014 Jul 18;289(29):19894-906. doi: 10.1074/jbc.M114.570739. Epub 2014 May 22. J Biol Chem. 2014. PMID: 24855652 Free PMC article.
-
Identification of inhibitors of HSF1 functional activity by high-content target-based screening.J Biomol Screen. 2009 Dec;14(10):1165-75. doi: 10.1177/1087057109347472. J Biomol Screen. 2009. PMID: 19820069
-
Feedback regulation of the heat shock response.Handb Exp Pharmacol. 2006;(172):43-68. doi: 10.1007/3-540-29717-0_2. Handb Exp Pharmacol. 2006. PMID: 16610354 Review.
-
Pleiotropic role of HSF1 in neoplastic transformation.Curr Cancer Drug Targets. 2014;14(2):144-55. doi: 10.2174/1568009614666140122155942. Curr Cancer Drug Targets. 2014. PMID: 24467529 Free PMC article. Review.
Cited by
-
FBXW7 modulates cellular stress response and metastatic potential through HSF1 post-translational modification.Nat Cell Biol. 2015 Mar;17(3):322-332. doi: 10.1038/ncb3121. Nat Cell Biol. 2015. PMID: 25720964 Free PMC article.
-
Confocal Laser Scanning Microscopy and Fluorescence Correlation Methods for the Evaluation of Molecular Interactions.Adv Exp Med Biol. 2021;1310:1-30. doi: 10.1007/978-981-33-6064-8_1. Adv Exp Med Biol. 2021. PMID: 33834430
-
Mutant p53 - Heat Shock Response Oncogenic Cooperation: A New Mechanism of Cancer Cell Survival.Front Endocrinol (Lausanne). 2015 Apr 22;6:53. doi: 10.3389/fendo.2015.00053. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 25954247 Free PMC article. Review.
-
Pharmaceutical inhibition of BCL6 ameliorates resistance to imatinib in chronic myeloid leukemia.Heliyon. 2024 Aug 22;10(16):e36640. doi: 10.1016/j.heliyon.2024.e36640. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39258188 Free PMC article.
-
Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells.BMC Cancer. 2016 Jul 16;16:487. doi: 10.1186/s12885-016-2490-z. BMC Cancer. 2016. PMID: 27421652 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
